HSAI
Hesai Group
HSAI has the edge over RIVN overall, supported by stronger fundamentals and stronger modeled upside.
RIVN
Rivian Automotive, Inc.
RIVN has lower modeled downside risk, despite its lower overall score.
HSAI Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Stable | |
| Healthy |
HSAI's revenue and balance sheet are currently healthy, and its profitability and cash flow are stable.
RIVN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
RIVN's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
HSAI PE Valuation
HSAI has no meaningful PE right now: it lost money over the past year.
RIVN PE Valuation
RIVN has no meaningful PE right now: it lost money over the past year.
HSAI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect strong earnings and revenue growth for HSAI, with profitability improving. However, they disagree widely on these estimates.
RIVN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RIVN's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
HSAI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $0.48 | +336% |
| Q1 2026 | $0.47 | +$0.49 |
| Q4 2025 | $0.43 | +$0.56 |
| Q3 2025 | $0.46 | +$0.92 |
| Q2 2025 | $0.11 | +$0.66 |
| Q1 2025 | -$0.02 | +$0.53 |
| Q4 2024 | -$0.13 | +$0.44 |
| Q3 2024 | -$0.46 | +$0.11 |
HSAI has the edge over RIVN on earnings quality, reporting a profit while its opponent remains loss making.
RIVN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.25 | +$0.83 |
| Q2 2026 | -$2.58 | +$0.62 |
| Q1 2026 | -$2.92 | +$0.77 |
| Q4 2025 | -$3.07 | +$1.62 |
| Q3 2025 | -$3.08 | +$2.52 |
| Q2 2025 | -$3.20 | +$2.76 |
| Q1 2025 | -$3.69 | +$2.08 |
| Q4 2024 | -$4.69 | +$1.05 |
RIVN is still losing money, but far less than before: $2.25 per share over the past year, against $7.40 at its worst in late 2022.
HSAI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $129.2M | +22% |
| Q1 2026 | $102.1M | +30% |
| Q4 2025 | $150.1M | +39% |
| Q3 2025 | $119.4M | +47% |
| Q2 2025 | $106M | +54% |
| Q1 2025 | $78.8M | +46% |
| Q4 2024 | $108M | +28% |
| Q3 2024 | $81M | +21% |
HSAI has the edge over RIVN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 0.3% | -3 points |
| Q1 2026 | -1.3% | +5.1 points |
| Q4 2025 | 5.7% | -9.1 points |
| Q3 2025 | 9.7% | +24 points |
| Q2 2025 | 3.2% | +24 points |
| Q1 2025 | -6.4% | +32 points |
| Q4 2024 | 15% | +44 points |
| Q3 2024 | -14% | +23 points |
HSAI has the edge over RIVN on profitability, with a higher operating margin.
RIVN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.2B | +38% |
| Q2 2026 | $1.7B | +27% |
| Q1 2026 | $1.4B | +11% |
| Q4 2025 | $1.3B | -26% |
| Q3 2025 | $1.6B | +78% |
| Q2 2025 | $1.3B | +13% |
| Q1 2025 | $1.2B | +3% |
| Q4 2024 | $1.7B | +32% |
RIVN's revenue is growing: $2.2B last quarter, up 38% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -41% | +22 points |
| Q2 2026 | -50% | +35 points |
| Q1 2026 | -64% | -11 points |
| Q4 2025 | -65% | -27 points |
| Q3 2025 | -63% | +71 points |
| Q2 2025 | -86% | +33 points |
| Q1 2025 | -53% | +70 points |
| Q4 2024 | -38% | +82 points |
RIVN's operating margin was −41% last quarter, up 22 points from the same quarter a year ago, near the top of its range since 2021.
HSAI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | $0 |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | $0 |
| Q3 2025 | $0 | $0 |
| Q2 2025 | $0 | $0 |
| Q1 2025 | $0 | $0 |
| Q4 2024 | $0 | $0 |
| Q3 2024 | $0 | $0 |
HSAI's free cash flow was $0 over the past year, against $0 the year before.
RIVN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.1B | -$703M |
| Q2 2026 | -$849M | -$451M |
| Q1 2026 | -$1.1B | -$549M |
| Q4 2025 | -$1.1B | -234% |
| Q3 2025 | -$421M | +$732M |
| Q2 2025 | -$398M | +$639M |
| Q1 2025 | -$526M | +$997M |
| Q4 2024 | $856M | +$2.3B |
RIVN has the edge over HSAI on cash flow, with more consistent year-over-year improvement.
HSAI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | +17% | +24M shares |
| 3 years | +30% | +37.5M shares |
| 5 years | +69% | +66.7M shares |
| Available history | +84% | +74.6M shares |
HSAI has the edge over RIVN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
HSAI hasn't bought back shares in the past year.
RIVN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +9.1% | +121M shares |
| 1 year | +19% | +226M shares |
| 3 years | +52% | +494M shares |
RIVN has 1.4B diluted shares, up 19% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | $6M |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
HSAI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -1.5x | Net Cash |
| Q1 2026 | -0.5x | Net Cash |
| Q4 2025 | -1.3x | Net Cash |
| Q3 2025 | -3.2x | Net Cash |
| Q2 2025 | -9.7x | Net Cash |
| Q1 2025 | -58.4x | Net Cash |
HSAI has more cash than debt.
RIVN Net Leverage
RIVN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HSAI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.4 | Neutral |
| Stochastic | 20.8 | Neutral |
HSAI's weekly RSI is 42 (neutral) and its Stochastic is 21 (neutral).
RIVN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 25.6 | Neutral |
RIVN's weekly RSI is 41 (neutral) and its Stochastic is 26 (neutral).
HSAI PE vs Consumer Cyclical Sector
| Metric | HSAI | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
HSAI has no meaningful PE right now: it lost money over the past year.
RIVN PE vs Consumer Cyclical Sector
RIVN has no meaningful PE right now: it lost money over the past year.
HSAI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $14.2 | 0.4% below |
| 20 week MA | $16.0 | 12% below |
| 50 week MA | $20.0 | 29% below |
| 100 week MA | $19.8 | 28% below |
RIVN has stronger trend alignment. HSAI is above 0 of 4 weekly averages versus RIVN above 0 of 5.
RIVN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.3 | 3.9% below |
| 20 week MA | $15.1 | 15% below |
| 50 week MA | $15.9 | 19% below |
| 100 week MA | $14.7 | 13% below |
| 200 week MA | $15.1 | 15% below |
RIVN is in a downtrend: it's below all five of its weekly moving averages, and 15% below its 200-week average.
HSAI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $22.2 | $8.91 | -60% |
| 2024 | $8.91 | $13.5 | +52% |
| 2025 | $13.5 | $22.5 | +67% |
| 2026 YTD | $22.5 | $14.2 | -37% |
HSAI has the edge over RIVN on returns for 2026, with the stronger performance.
RIVN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $130.0 | $96.8 | -25% |
| 2022 | $96.8 | $19.1 | -80% |
| 2023 | $19.1 | $23.5 | +23% |
| 2024 | $23.5 | $13.7 | -42% |
| 2025 | $13.7 | $20.9 | +53% |
| 2026 YTD | $20.9 | $12.8 | -39% |
RIVN has finished lower in three of the last five years. It's down 39% so far in 2026.